Member Info for brafty

We will find out on the 5 May 2026 during the live presentation , but the CFO bailing not great !

Now break even with a global product 0.30p or 0.40p what s your estimate it will get snapped up for Servalan ?

My prediction is AOP will want 30 - 40 p to avoid making a loss and make some profit

Could be a new RNS soon Pre-Christmas after dropping this ?

Since Anders Lundstrom the new CEO took over they have had significant growth to date climbed from a 52-week low of 2.1p to a recent high of 9.4p . The management team experience have proven this in results over the last year , they know what they are doing and have grown shield in different areas of the globe . Next year the assumption on wider adoption and breakeven will defiantly be factors in the rise of the share price and more confidence in once a failing stock from the pervious bad management . hopefully no banana skins next year .

Great News ! ACCRUFeR® receives Marketing Authorisation by Korean Ministry of Food and Drug Safety (MFDS)

I THINK IT WILL BE BOUGHT OUT BETWEEN 20 - 30 P JUST AS IT GETS GOING , HOPEFULLY NOT AS IM HAPPY TO RIDE THIS WAVE TO THE TOP .

Great where is this documented could you put a link up ?

Amazing ! This stock looked dead , bravo the management team

Was this because the old CEO got sacked ? Amazing to see what good management can achieve in a year !

Big buys coming in , what's the news ?

Pharma exempt from tariffs , i ve heard ?

https://www.fiercehealthcare.com/finance/trump-signs-orders-imposing-10-minimum-tariff-plus-broader-reciprocal-tariffs-and-de